UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2012
OR
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number: 0-13111
AXION INTERNATIONAL HOLDINGS, INC
(Exact name of registrant as specified in its charter)
Colorado | 84-0846389 |
(State or other jurisdiction of incorporation or organization) | (IRS Employer Identification No.) |
180 South Street, Suite 104, New Providence, NJ 07974
(Address of principal executive offices)
908-542-0888
(registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes¨ No¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes¨ No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer¨ | Accelerated filer¨ |
Non-accelerated filer¨ | Smaller reporting companyþ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes¨ Noþ
The number of outstanding shares of the registrant’s common stock, without par value, as of May 16, 2012 was 25,988,550.
TABLE OF CONTENTS
PAGE | ||
PART I. FINANCIAL INFORMATION | ||
Item 1. | Financial Statements | 3 |
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 23 |
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 29 |
Item 4. | Controls and Procedures | 29 |
PART II. OTHER INFORMATION | ||
Item 1. | Legal Proceedings | 31 |
Item 2. | Unregistered Sales of Securities and Use of Proceeds | 31 |
Item 3. | Defaults Upon Senior Securities | 31 |
Item 4. | Mine Safety Disclosures | 31 |
Item 5. | Other Information | 31 |
Item 6. | Exhibits | 32 |
SIGNATURES | 33 |
2 |
PART 1. FINANCIAL INFORMATION
Item 1. Financial Statements.
AXION INTERNATIONAL HOLDINGS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
March 31, | December 31, | |||||||
2012 | 2011 | |||||||
(Unaudited) | ||||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 1,107,837 | $ | 1,982,772 | ||||
Accounts receivable | 863,273 | 701,155 | ||||||
Inventories | 1,168,372 | 1,528,491 | ||||||
Prepaid expenses | 350,386 | 203,445 | ||||||
Total current assets | 3,489,868 | 4,415,863 | ||||||
Property and equipment, net | 1,539,466 | 1,047,136 | ||||||
Other long-term and intangible assets | 74,997 | 78,997 | ||||||
Total assets | $ | 5,104,331 | $ | 5,541,996 | ||||
LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 2,013,182 | $ | 1,175,462 | ||||
Accrued liabilities | 399,624 | 359,715 | ||||||
Revolving credit facility, net of discounts | 262,529 | 160,794 | ||||||
Derivative liability – conversion options | 127,071 | 113,271 | ||||||
Derivative liability - warrants | - | 1,875,463 | ||||||
Current portion of convertible debt, net of discount | 497,142 | 566,785 | ||||||
Total current liabilities | 3,299,548 | 4,251,490 | ||||||
Fair value of 10% convertible preferred stock warrants | 244,997 | 487,555 | ||||||
Total liabilities | 3,544,545 | 4,739,045 | ||||||
Commitments and contingencies | - | - | ||||||
10% Convertible preferred stock, no par value; authorized 880,000 shares; 746,023 and 752,273 shares issued and outstanding at March 31, 2012 and December 31, 2011, respectively | 5,695,009 | 5,520,256 | ||||||
Redeemable common stock, no par value; 250,000 shares issued and outstanding at March 31, 2012 and December 31, 2011 | 242,500 | 242,500 | ||||||
Stockholders' deficit: | ||||||||
Common stock, no par value; authorized, 100,000,000 shares; 25,442,299 and 25,007,261 shares issued and outstanding at March 31, 2012 and December 31, 2011, respectively | 25,803,478 | 23,660,071 | ||||||
Accumulated deficit | (30,181,201 | ) | (28,619,876 | ) | ||||
Total stockholders' deficit | (4,377,723 | ) | (4,959,805 | ) | ||||
Total liabilities and stockholders' deficit | $ | 5,104,331 | $ | 5,541,996 |
(See accompanying notes to the unaudited condensed consolidated financial statements.)
3 |
AXION INTERNATIONAL HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE THREE MONTHS ENDED MARCH 31
(Unaudited)
2012 | 2011 | |||||||
Revenue | $ | 2,296,573 | $ | 190,887 | ||||
Costs of sales | 2,285,450 | 275,389 | ||||||
Gross margin (loss) | 11,123 | (84,502 | ) | |||||
Operating expenses: | ||||||||
Product development and quality management | 235,479 | 73,395 | ||||||
Marketing and sales | 138,772 | 59,061 | ||||||
General and administrative | 835,391 | 1,478,713 | ||||||
Total operating costs and expenses | 1,209,642 | 1,611,169 | ||||||
Loss from operations | (1,198,519 | ) | (1,695,671 | ) | ||||
Other expense: | ||||||||
Interest expense | 37,974 | 30,080 | ||||||
Amortization of debt and preferred stock discounts | 311,032 | 204,140 | ||||||
Change in fair value of derivative liability | 13,800 | - | ||||||
Total other expense | 362,806 | 234,220 | ||||||
Loss before provision for income taxes | (1,561,325 | ) | (1,929,891 | ) | ||||
Provision for income taxes | - | - | ||||||
Net loss | (1,561,325 | ) | (1,929,891 | ) | ||||
Accretion of preferred stock dividends and beneficial conversion feature | (345,526 | ) | (3,859 | ) | ||||
Net loss attributable to common shareholders | $ | (1,906,851 | ) | $ | (1,933,750 | ) | ||
Weighted average common shares - basic and diluted | 25,630,321 | 23,461,790 | ||||||
Basic and diluted net loss per share | $ | (0.07 | ) | $ | (0.08 | ) |
(See accompanying notes to the unaudited condensed consolidated financial statements.)
4 |
AXION INTERNATIONAL HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIT
FOR THE PERIOD FROM JANUARY 1, 2012 THROUGH MARCH 31, 2012
(Unaudited)
Common Shares | Additional Paid-in Capital and Common Stock |
Accumulated Deficit | Total | |||||||||||||
Balance, January 1, 2012 | 25,007,261 | $ | 23,660,071 | $ | (28,619,876 | ) | $ | (4,959,805 | ) | |||||||
Shares issued for services rendered | 125,000 | 90,000 | 90,000 | |||||||||||||
Shares issued upon conversion of 10% convertible preferred stock | 62,500 | 62,500 | 62,500 | |||||||||||||
Shares issued for dividend payments | 247,538 | 176,620 | 176,620 | |||||||||||||
Share-based compensation | 284,350 | 284,350 | ||||||||||||||
Accretion of dividend on 10% convertible preferred stock | (171,751 | ) | (171,751 | ) | ||||||||||||
Accretion of beneficial conversion feature of 10% convertible preferred stock | (173,775 | ) | (173,775 | ) | ||||||||||||
Issue warrants as a result of reset of 10% convertible preferred stock | 1,875,463 | 1,875,463 | ||||||||||||||
Net loss | (1,561,325 | ) | (1,561,325 | ) | ||||||||||||
Balance, March 31, 2012 | 25,442,299 | $ | 25,803,478 | $ | (30,181,201 | ) | $ | (4,377,723 | ) |
(See accompanying notes to the unaudited condensed consolidated financial statements.)
5 |
AXION INTERNATIONAL HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED MARCH 31
(Unaudited)
2012 | 2011 | |||||||
Cash flow from operating activities: | ||||||||
Net loss | $ | (1,561,325 | ) | $ | (1,929,891 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation, and amortization | 34,244 | 40,084 | ||||||
Accretion of convertible debt discount | 102,857 | 204,140 | ||||||
Accretion of preferred stock discount | 68,347 | - | ||||||
Accretion of revolving credit agreement discount | 101,735 | - | ||||||
Change in fair value of 10% convertible preferred stock warrants | (242,558 | ) | - | |||||
Change in fair value of derivative liability | 13,800 | - | ||||||
Share-based compensation | 374,350 | 1,026,248 | ||||||
Changes in operating assets and liability: | ||||||||
Accounts receivable | (162,118 | ) | (190,053 | ) | ||||
Inventories | 360,119 | (271,672 | ) | |||||
Prepaid expenses and deposits | (142,941 | ) | 18,186 | |||||
Accounts payable | 837,720 | (73,602 | ) | |||||
Accrued liabilities | 39,909 | (20,681 | ) | |||||
Net cash used in operating activities | (175,861 | ) | (1,197,241 | ) | ||||
Cash flows from investing activities: | ||||||||
Purchase of property and equipment | (526,574 | ) | (91,475 | ) | ||||
Net cash used in investing activities | (526,574 | ) | (91,475 | ) | ||||
Cash flows from financing activities: | ||||||||
Proceeds from issuance of 10% convertible preferred stock, net | - | 1,395,079 | ||||||
Issuance of common stock, net of expenses | - | 200 | ||||||
Repayments of convertible debt | (172,500 | ) | - | |||||
Repayment of short term notes | - | (9,391 | ) | |||||
Net cash (used in) provided by financing activities | (172,500 | ) | 1,385,888 | |||||
Net (decrease) increase in cash | (874,935 | ) | 97,172 | |||||
Cash and cash equivalents at beginning of period | 1,982,772 | 785,612 | ||||||
Cash and cash equivalents at end of period | $ | 1,107,837 | $ | 882,784 | ||||
Supplemental disclosures of cash flow information: | ||||||||
Cash paid for interest | $ | 37,974 | $ | 29,947 | ||||
Conversion of 10% convertible preferred Stock | 62,500 | - | ||||||
Conversion of note | - | 60,000 | ||||||
Accretion of dividends on 10% convertible preferred stock | 171,751 | 3,859 | ||||||
Fair value of warrants issued on reset of 10% convertible preferred stock | 1,875,463 | - |
(See accompanying notes to the unaudited condensed consolidated financial statements.)
6 |
AXION INTERNATIONAL HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2012
(Unaudited)
Note 1 - Summary of Significant Accounting Policies
(a) Business and Basis of Financial Statement Presentation
Axion International Holdings, Inc. (“Holdings” or the “Company”) was formed in 1981. In November 2007, Holdings entered into an Agreement and Plan of Merger, among Holdings, Axion Acquisition Corp., a Delaware corporation and a newly created direct wholly-owned subsidiary of Holdings (the “Merger Sub”), and Axion International, Inc., a Delaware corporation which incorporated on August 6, 2006 with operations commencing in November 2007 (‘Axion”). On March 20, 2008 (the “Effective Date”), Holdings consummated the merger (the “Merger”) of Merger Sub into Axion, with Axion continuing as the surviving corporation and a wholly-owned subsidiary of Holdings. The accompanying consolidated financial statements represent those of Axion for all periods prior to the consummation of the Merger.
Our consolidated financial statements include the accounts of our wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
On January 18, 2011, the Board of Directors approved a change in the Company’s fiscal year end from September 30 to December 31. We filed a transitional report for the three month period ended December 31, 2010 on Form 10-KT on May 2, 2011.
The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with Rule S-X of the Securities and Exchange Commission and with the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.
In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. However, the results from operations for the three months ended March 31, 2012, are not necessarily indicative of the results that may be expected for the year ending December 31, 2012. The unaudited condensed consolidated financial statements should be read in conjunction with the consolidated December 31, 2011 financial statements and footnotes thereto included in the Company's Form 10-K/A filed with the SEC.
On May 14, 2011, we filed with the Securities and Exchange Commission (“SEC”) a Current Report on Form 8-K, to report our determination that our consolidated financial statements for the year ended December 31, 2011, included in our Annual Report on Form 10-K filed with the SEC on March 6, 2012 (the “2011 Form 10-K”), should not be relied upon because we failed (i) to initially record and subsequently fair value our derivative warrant liabilities in connection with the issuances of our 10% Convertible Preferred Stock (the “Preferred Stock”) on March 22, 2011, April 1, 2011, April 13, 2011 and April 21, 2011 and (ii) to recalculate the fair value of the beneficial conversion feature embedded in the Preferred Stock upon determination that the conversion price of the Preferred Stock was required to be reset. We determined that the historical consolidated financial statements for the year ended December 31, 2011 included in our 2011 Form 10-K require restatement (i) to record the change in fair value of our derivative warrant liability and (ii) to recalculate the fair value of the beneficial conversion feature and the amortization thereon in our Consolidated Statement of Stockholder Deficit.
On May 21, 2012, we filed our Form 10-K/A restating our financial statements and other disclosures where necessary, to properly account for these issues.
(b) Cash and Cash Equivalents
For purposes of the statement of cash flows, we consider all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents.
(c) Property and Equipment
Property and equipment are recorded at cost and are depreciated and amortized using the straight-line method over estimated useful lives of two to twenty years. Costs incurred that extend the useful life of the underlying asset are capitalized and depreciated over the remaining useful life. Repairs and maintenance are charged directly to operations as incurred.
As required by ASC 350-40, Internal-Use Software, the Company capitalizes costs related to internally developed software. Only costs incurred during the development stages, including design, coding, installation and testing are capitalized. These capitalized costs primarily represent internal labor costs for employees directly associated with the software development. Upgrades or modifications that result in additional functionality are capitalized.
7 |
Our property and equipment is comprised of the following:
March 31, 2012 | December 31, 2011 | |||||||
Property, equipment, and leasehold improvements, at cost: | ||||||||
Equipment | $ | 13,754 | $ | 13,754 | ||||
Machinery and equipment | 2,079,078 | 1,618,701 | ||||||
Purchased software | 123,551 | 56,404 | ||||||
Furniture and fixtures | 13,090 | 14,040 | ||||||
2,229,473 | 1,702,899 | |||||||
Less accumulated depreciation | (690,007 | ) | (655,763 | ) | ||||
Net property and leasehold improvements | $ | 1,539,466 | $ | 1,047,136 |
Depreciation expense included as a charge to costs of sales and general and administrative expenses was $33,918 and $326, respectively for the three months ended March 31, 2012. Depreciation expense for the three months ended March 31, 2011 was $40,084.
(d) Allowance for Doubtful Accounts
We accrue a reserve on a receivable when, based upon the judgment of management, it is probable that a receivable will not be collected and the amount of any reserve may be reasonably estimated. As of March 31, 2012 and December 31, 2011, we provided an allowance of $32,731 for doubtful accounts.
(e) Revenue and Cost Recognition
In accordance with FASB ASC 605 “Revenue Recognition”, revenue is recognized when persuasive evidence of an agreement with the customer exists, products are shipped or title passes pursuant to the terms of the agreement with the customer, the amount due from the customer is fixed or determinable, collectability is reasonably assured, and there are no significant future performance obligations.
We recognize revenue when a fixed commitment to purchase the products is received, title or ownership has passed to the customer and we do not have any specific performance obligations remaining, such that the earnings process is complete. In most cases, we receive a purchase order from our customer specifying the products requested and delivery instructions. We recognize revenue upon our delivery of the products as specified in the purchase order.
In other cases where we have a contract which provides for a large number of products and few actual deliveries, the revenues are recorded each month as the products are produced and the risk of ownership passes to the customer upon pre-delivery acceptance. Prior to deliveries, our customer’s products are segregated from our inventory and not available for fulfilling other orders.
Under our third-party contract manufacturing arrangements, our costs of sales are predominately comprised of the cost of raw materials and the costs and expenses associated with the third-party manufacturer producing the finished product. Under one arrangement, we purchase and supply the raw materials to the third-party manufacturer who we pay a per-pound cost to produce the finished product. Under our other arrangement the third-party manufacturer sources and pays for the raw materials and we purchase the finished product from them at a cost per unit. In addition, for that arrangement, we are responsible for any costs of raw materials purchased by the third-party manufacturer in excess of the arrangement’s reference prices and we share any savings for purchases below the reference prices. Our costs of sales may vary significantly as a result of the variability in the cost of our raw materials and the efficiency with which we plan and execute our manufacturing processes.
We do not believe warranty obligations are significant.
8 |
(f) Income Taxes
We use the asset and liability method of accounting of income taxes pursuant to the provisions of FASB ASC 740 “Income Taxes”, which establishes deferred tax assets and liabilities to be recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.
(g) Impairment of Long-Lived Assets Other Than Goodwill
We assess the potential for impairment in the carrying values of our long-term assets whenever events or changes in circumstances indicate such impairment may have occurred. An impairment charge to current operations is recognized when the estimated undiscounted future net cash flows of the asset are less than its carrying value. Any such impairment is recognized based on the differences in the carrying value and estimated fair value of the impaired asset.
(h) Derivative Instruments
For derivative instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in fair value recognized in earnings each reporting period. We use the Black-Scholes model to value the derivative instruments at inception and subsequent valuation dates and is re-assessed at the end of each reporting period, in accordance with FASB ASC Topic 815,“Derivatives and Hedging”. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date.
9 |
(i) Share-Based Compensation
We record share-based compensation for transactions in which we exchange our equity instruments for services of employees, consultants and others based on the fair value of the equity instruments issued at the date of grant or other measurement date. The fair value of common stock awards is based on the observed market value of our stock. We calculate the fair value of options and warrants using the Black-Scholes option pricing model. Expense is recognized, net of expected forfeitures, over the period of performance. When the vesting of an award is subject to performance conditions, no expense is recognized until achievement of the performance condition is deemed to be probable. Options issued to consultants are marked to market at each reporting date.
(j) Earnings (Loss) Per Share
Basic earnings (loss) per share are computed by dividing earnings (loss) available to common shareholders by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per share includes the effects of the potential dilution of outstanding options, warrants, and convertible debt on our common stock as determined using the treasury stock method. For the three months ended March 31, 2012 and 2011, there were no dilutive effects of such securities because we incurred a net loss in each period. As of March 31, 2012, we have approximately 24.5 million potential common shares issuable under our convertible instruments, warrant and stock option agreements.
(k) Fair Value of Financial Instruments
In January 2008, we adopted the provisions under FASB for Fair Value Measurements, which define fair value for accounting purposes, establishes a framework for measuring fair value and expands disclosure requirements regarding fair value measurements. Our adoption of these provisions did not have a material impact on our consolidated financial statements. Fair value is defined as an exit price, which is the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date. The degree of judgment utilized in measuring the fair value of assets and liabilities generally correlates to the level of pricing observability. Financial assets and liabilities with readily available, actively quoted prices or for which fair value can be measured from actively quoted prices in active markets generally have more pricing observability and require less judgment in measuring fair value. Conversely, financial assets and liabilities that are rarely traded or not quoted have less price observability and are generally measured at fair value using valuation models that require more judgment. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency of the asset, liability or market and the nature of the asset or liability. We have categorized our financial assets and liabilities that are recurring at fair value into a three-level hierarchy in accordance with these provisions.
(l) Concentration of Credit Risk
We maintain our cash with two major U.S. domestic banks. The amount held in these banks exceeds the insured limit of $250,000 from time to time and was approximately $0.6 million at March 31, 2012. We have not incurred losses related to these deposits. Our accounts receivable balance as of March 31, 2012 of approximately $0.9 million consists of amounts due from a limited number of customers.
(m) Operating Cycle
In accordance with industry practice, we may include in current assets and liabilities amounts relating to long-term contracts, which generally have operating cycles extending beyond one year. Other assets and liabilities are classified as current and non-current on the basis of expected realization within or beyond one year.
(n) Use of Estimates
The preparation of our financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in these financial statements and accompanying notes. Actual results could differ from those estimates.
10 |
(o) Redeemable Common Stock
We account for redeemable common stock in accordance with ASC 480-10-S99-3A “Classification and Measurement of Redeemable Securities,” which provides that securities that are redeemable for cash or other assets are classified outside of permanent equity if they are redeemable at the option of the holder. Accordingly, 250,000 shares of common stock issued as a commitment fee, pursuant to the revolving credit agreement are classified outside of permanent equity at redemption value. When circumstances indicate it is probable the holder may redeem these shares of commont stock, we recognize changes in the redemption value in the period they occur and adjust the carrying value of the redeemable common stock to equal its redemption value at the end of each reporting period.
(p) Recent Accounting Pronouncements
In May 2011, the FASB issued Accounting Standards Update (ASU) 2011-04, “Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs”, which amends ASC 820, “Fair Value Measurement”. ASU 2011-04 does not extend the use of fair value accounting, but provides guidance on how it should be applied where its use is already required or permitted by other standards within U.S. GAAP or International Financial Reporting Standards (IFRSs). ASU 2011-04 changes the wording used to describe many requirements in U.S. GAAP for measuring fair value and for disclosing information about fair value measurements. Additionally, ASU 2011-04 clarifies the FASB’s intent about the application of existing fair value measurements. ASU 2011-04 became effective for the Company January 1, 2012. The adoption of ASU 2011-04 did not have an impact on the Company’s consolidated financial statements.
(q) Going Concern
The accompanying financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America, which contemplates our continuation as a going concern. At March 31, 2012, we have working capital of approximately $190,000, a stockholders’ deficit of approximately $4.4 million and have accumulated losses to date of approximately $30.2 million. This raises substantial doubt about our ability to continue as a going concern. In view of these matters, realization of certain of the assets in the accompanying balance sheet is dependent upon our ability to meet our financing requirements, raise additional capital, and the success of our business plan and future operations. We are seeking additional means of financing to fund our business plan. There is no assurance that we will be successful in raising sufficient funds to assure our eventual profitability. We believe that actions planned and presently being taken to revise our operating and financial requirements provide us the opportunity to continue as a going concern. The financial statements do not include any adjustments that might result from these uncertainties.
Note 2 – Inventories
Inventories are priced at the lower of cost or market and consist primarily of raw materials, parts for assembling our finished products and finished products. No material adjustment has been made to the cost of finished products inventories as of March 31, 2012 and December 31, 2011.
March 31, 2012 | December 31, 2011 | |||||||
Finished products | $ | 847,710 | $ | 1,032,798 | ||||
Production materials | 320,662 | 495,693 | ||||||
Total inventories | $ | 1,168,372 | $ | 1,528,491 |
Since we engage third-party contract manufacturers to produce our finished products, and in certain situations we provide them the raw materials, our inventories at March 31, 2012 and December 31, 2011 are located at the third-party contract manufacturing locations. We carry adequate insurance for loss on this inventory.
Note 3 - Accrued Liabilities
The components of accrued liabilities are:
March 31, 2012 | December 31, 2011 | |||||||
Royalties | $ | 231,477 | $ | 239,129 | ||||
Payroll | 29,611 | 54,325 | ||||||
Sales tax payable | 34,391 | 29,112 | ||||||
Insurance premiums payable | - | 20,320 | ||||||
Interest | 27,315 | - | ||||||
Miscellaneous | 76,830 | 16,829 | ||||||
Total accrued liabilities | $ | 399,624 | $ | 359,715 |
Note 4 - Convertible Revolving Credit Agreement
During the year ended December 31, 2011, we entered into a convertible revolving credit agreement (the Agreement”) with a private investor (Lender”). Under the terms of the Agreement, Lender has agreed to lend us up to $2,000,000 on a revolving basis (the Loan”). The Loan bears interest at 12% per annum on the outstanding principal amount. The Lender may elect to have all or a portion of accrued interest paid in shares of our common stock. The common stock shall be valued at the lessor of (a) $0.80 per share or (b) $0.10 per share less than the variable weighted average price (VWAP”) for our common stock for the thirty days ending one trading prior to the date of issuance of such shares. The Loan will mature on September 30, 2012.
11 |
The Lender may convert up to fifty percent of the trailing ninety day average of outstanding principal amount under the Loan into shares of our common stock. Such common stock shall be valued at the lessor of (a) $0.80 per share or (b) $0.10 per share less than the VWAP for our common stock for any thirty days ending one trading prior to the date of issuance of such shares.
In consideration for the Loan, we issued to Lender 250,000 shares of our restricted common stock. We have agreed to register the common stock issued to Lender within six months from date of closing provided, however, if such common stock is not registered Lender may redeem all of Lender’s unregistered stock in cash at a price equal to the greater of (a) the average VWAP for the thirty days ending one trading day prior to the date of issuance or (b) $0.90 per share. Lender agreed to waive any notice requirements under the Agreement in connection with our sale of certain securities pursuant to a registration statement on Form S-1, which we initially filed on December 22, 2011 and may amend from time to time thereafter. We accounted for this redeemable common stock outside of permanent equity at redemption value and if it is probable that the holder will redeem the restricted common stock pursuant to this provision, we recognize changes in the redemption value in the period it occurs and adjust the carrying value of the redeemable common stock to equal its redemption value at the end of each reporting period.
The fair value at issuance of the shares given as consideration and the fair value of the beneficial conversion feature were recorded as a discount to the revolving credit agreement outstanding loan, and are amortized over the term of the revolving credit agreement. During the three months ended March 31, 2012, we amortized $101,735 of the revolving credit agreement discount to other expenses in our statement of operations. The unamortized balance will be fully amortized through the maturity date - September 30, 2012.
We gave Lender a security interest in our inventory and accounts receivable pursuant to terms of a security agreement.
During the year ended December 31, 2011, we borrowed $466,000 under the Agreement, which remained outstanding at March 31, 2012.
The components of convertible revolving credit agreement are summarized as follows:
Due | March 31, 2012 | December 31, 2011 | ||||||||||
12% convertible debt | September 30, 2012 | $ | 466,000 | $ | 466,000 | |||||||
Debt discount | (203,471 | ) | (305,206 | ) | ||||||||
Total | $ | 262,529 | $ | 160,794 |
Subsequent to March 31, 2012, we repaid all outstanding principal and accrued interest under the convertible revolving credit agreement and the agreement was cancelled.
Note 5 - Derivative Liabilities
Conversion Option
The convertible revolving credit agreement (see Note 4) entered into during the year ended December 31, 2011 meets the definition of a hybrid instrument, as defined in ASC Topic 815 “Derivatives and Hedging”. The hybrid instrument is comprised of a (i) a debt instrument, as the host contract and (ii) an option to convert the debt outstanding under the revolving credit agreement into shares of our common stock, as an embedded derivative. The embedded derivative derives its value based on the underlying fair value of the shares of our common stock. The embedded derivative is not clearly and closely related to the underlying host debt instrument since the economic characteristics and risk associated with this derivative are based on the common stock fair value.
We determined the fair value of the embedded derivative and recorded it as a discount to the debt and a derivative liability on the date of issue. The discount is amortized to other expenses over the term of the revolving credit agreement and will be fully amortized at the maturity of the agreement on September 30, 2012. Upon conversion of the debt to equity, any remaining unamortized discount is charged to financing expense.
The embedded derivative does not qualify as a fair value or cash flow hedge under ASC 815. Accordingly, changes in the fair value of the embedded derivative are immediately recognized in earnings and classified as a gain or loss on the embedded derivative financial instrument in the accompanying statements of operations. We recognized a loss of $13,800 for the three months ended March 31, 2012.
12 |
Warrants
The 10% convertible preferred stock (see Note 7) issued during the year ended December 31, 2011 meets the definition of a hybrid instrument, as defined in ASC Topic 815 “Derivatives and Hedging” (”ASC 815”). The hybrid instrument is comprised of a (i) a preferred stock, as the host contract, (ii) a warrant to purchase shares of our common stock to be issued if a certain revenue milestone is not achieved (the “Make Good Warrant”), as an embedded derivative liability and (iii) an option to convert the preferred stock into shares of our common stock (the “Conversion Option”). Since, at issuance the number of shares of common stock which the Make Good Warrant would be exercisable into, was not known, ASC 815 requires the fair value of the Make Good Warrants be recorded as a derivative liability at issuance and any change in fair value be recognized in current earnings. The Conversion Option derives its value based on the underlying fair value of the shares of our common stock as does the Preferred Stock, and therefore is clearly and closely related to the underlying host contract.
The Make Good Warrant derivative does not qualify as a fair value or cash flow hedge under ASC 815. Accordingly, changes in the fair value of the derivative are immediately recognized in earnings and classified as a gain or loss on the derivative financial instrument in the accompanying statements of operations. At the date of issuance in March and April 2011, we determined the fair value of the Make Good Warrant derivative to be insignificant and did not record a charge to Common Stock and a credit to the derivative liability. Later in 2011, since it became probable that the revenue milestone would not be met, we recorded the derivative liability at fair value of $1.9 million. Since we did not achieve the revenue milestone for the year ended December 31, 2011, we were required to issue the Make Good Warrants, and accordingly once issued, the derivative liability associated with the Make Good Warrants was satisfied and the fair value reduced to zero. Therefore, January 1, 2012 we credited Common Stock for the issuance of these warrants for the fair value of the derivative liability of approximately $1.9 million.
We are required to disclose the fair value measurements required by Accounting for Fair Value Measurements. The derivative liability recorded at fair value in the balance sheet as of March 31, 2012 and December 31, 2011 is categorized based upon the level of judgment associated with the inputs used to measure its fair value. Hierarchical levels, defined by Accounting for Fair Value Measurements are directly related to the amount of subjectivity associated with the inputs to fair valuation of the liability is as follows:
Level 1 - | Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date; |
Level 2 - | Inputs other than Level 1 inputs that are either directly or indirectly observable; and |
Level 3 - | Unobservable inputs, for which little or no market data exist, therefore requiring an entity to develop its own assumptions. |
The following table summarizes the financial liabilities measured at fair value on a recurring basis as of March 31, 2012 and December 31, 2011, segregated by the level of the valuation inputs within the fair value hierarchy utilized to measure fair value:
As of March 31, 2012 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Liabilities at Fair Value | |||||||||||||
Derivative liability – conversion option | $ | - | $ | - | $ | 127,071 | $ | 127,071 | ||||||||
Derivative liability – warrants | - | - | - | - | ||||||||||||
Placement agent warrants | - | - | 244,997 | 244,997 | ||||||||||||
Total | $ | - | $ | - | $ | 372,068 | $ | 372,068 |
As of December 31, 2011 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Liabilities at Fair Value | |||||||||||||
Derivative liability – conversion option | $ | - | $ | - | $ | 113,271 | $ | 113,271 | ||||||||
Derivative liability – warrants | - | - | 1,875,463 | 1,875,463 | ||||||||||||
Placement agent warrants | - | - | 487,555 | 487,555 | ||||||||||||
Total | $ | - | $ | - | $ | 2,476,289 | $ | 2,476,289 |
13 |
The following table is a reconciliation of the derivative liability for which Level 3 inputs were used in determining fair value:
Conversion Option | Warrants | Placement Agent Warrants | ||||||||||
Beginning balance as of January 1, 2012 | $ | 113,271 | $ | 1,875,463 | $ | 487,555 | ||||||
Loss (gain) in fair value | 13,800 | - | (242,558 | ) | ||||||||
Credited to common stock upon issuance of Warrants | - | (1,875,463 | ) | - | ||||||||
Ending balance as of March 31, 2012 | $ | 127,071 | $ | - | $ | 244,997 |
In accordance with “Accounting for Derivative Instruments and Hedging”, we calculated the fair value of the revolving credit agreement conversion feature using the Black-Scholes option pricing model and the assumptions used in the model were as follows:
March 31, 2012 | ||||
Expected volatility | 99 | % | ||
Expected life (months) | 6 | |||
Risk free interest rate | 0.15 | % | ||
Forfeiture rate | - | |||
Dividend rate | - |
Note 6 - Convertible Debt
The components of debt are summarized as follows.
Due | March 31, 2012 | December 31, 2011 | ||||||||||
10% convertible debentures | June 2012 | $ | 600,000 | $ | 600,000 | |||||||
8.75% convertible debenture | January 2012 | - | 172,500 | |||||||||
Subtotal - principal | 600,000 | 772,500 | ||||||||||
Debt discount | (102,858 | ) | (205,715 | ) | ||||||||
497,142 | 566,785 | |||||||||||
Less: current portion | (497,142 | ) | (566,785 | ) | ||||||||
Total long term debt | $ | - | $ | - |
10% Convertible Debentures
Our 10% convertible debentures were issued under purchase agreements during the year ended September 30, 2009, together with warrants, for aggregate proceeds of $600,000. The total of the fair value of the warrants, as determined using the Black-Scholes pricing model, and the value of the beneficial conversion features contained in the debentures, representing the difference between the fair value of common stock issuable upon conversion at the date of purchase and the amount of proceeds allocated to the note, exceeded the proceeds received. Accordingly, we recorded a discount on the debentures equal to the principal amount of the debentures. The recorded discount on these debentures is to be amortized to interest expense on the interest method through their scheduled maturity dates.
Effective January 14, 2011, the holders of our 10% Convertible Debentures, originally due in February and March 2011, agreed to extend the maturity dates to June 30, 2012 and to the elimination of the prohibition of paying dividends or distributions on any of our equity securities. We agreed to amend the interest rate to 15% if paid in cash and to 18% (from 12%) if paid with shares of our common stock at the rate of one share of common stock for each $0.60 (from $0.90) of interest. We also agreed to reduce the conversion price, as defined, to $0.60, from $0.90 and to amend the volume weighted average trading price at which we could force conversion to $2.50 from $2.00. In addition, for each calendar month after February or March 2011 that these debentures remain outstanding, we will issue a warrant exercisable for three years for a number of shares of our common stock equal to the 5% of the outstanding principal divided by $0.90. These warrants will be exercisable at $0.90 per share.During the three months ended March 31, 2012, we issued such warrants with fair values of $38,093 as determined by the Black-Scholes option pricing model, which has been charged to interest expense.
14 |
Even though these modifications to our 10% Convertible Debentures resulted in less than a ten percent difference in the present value of cash flows between the original terms and the modified terms, the fair value of the conversion options was substantially greater than ten percent. We have therefore, accounted for the modification of these debentures as an extinguishment of the original debt and the establishment of new debt. Under the terms of the modified 10% Convertible Debentures, the total of the fair value of the warrants, as determined using the Black-Scholes pricing model, and the value of the beneficial conversion features contained in the debentures, representing the difference between the fair value of common stock issuable upon conversion at the date of purchase and the amount of proceeds allocated to the debenture, exceeded the proceeds received. Accordingly, effective with the date of amendment, we recorded a discount on the debentures equal to the principal amount of the debentures. The recorded discount on these debentures is to be amortized to interest expense on the interest method through their scheduled maturity dates. During the three months ended March 31, 2012, we amortized $102,857 of the modified discount to interest expense. The remaining unamortized discounts at March 31, 2012 will be fully amortized at maturity in June 2012.
8.75% Convertible Debenture
At maturity on January 31, 2012, we repaid the full principal plus accrued interest on our 8.75% convertible debenture.
Note 7 - 10% Convertible Redeemable Preferred Stock
We designated 880,000 shares of preferred stock as 10% Convertible Preferred Stock (the “Preferred Stock”). The Preferred Stock has a stated value (the “Stated Value”) of $10.00 per share. The Preferred Stock and any dividends thereon may be converted into shares of our common stock at any time by the holder at a conversion rate, as adjusted (the “Conversion Rate”). The holders of the Preferred Stock are entitled to receive dividends at the rate of ten percent (10%) per annum payable quarterly. Dividends shall not be declared, paid or set aside for any series or other class of stock ranking junior to the Preferred Stock, until all dividends have been paid in full on the Preferred Stock. The dividends on the Preferred Stock are payable, at our option, in cash, if permissible, or in additional shares of common stock. The Preferred Stock is not subject to any anti-dilution provisions other than for stock splits and stock dividends or other similar transactions. The holders of the Preferred Stock shall have the right to vote with our stockholders in any matter. The number of votes that may be cast by a holder of our Preferred Stock shall equal the Stated Value of the Preferred Stock purchased divided by the Conversion Rate. The Preferred Stock shall be redeemable for cash by the holder any time after the three (3) year anniversary from the initial purchase. The Preferred Stock may be converted by us, provided that the variable weighted average price of our common stock has closed at $4.00 per share or greater, for sixty (60) consecutive trading days and during such sixty (60) day period, the shares of common stock issuable upon conversion of the Preferred Stock have either been registered for resale or are issuable without restriction pursuant to Rule 144 of the Securities Act of 1933, as amended.
Pursuant to the terms of the Preferred Stock, since our net revenues for the twelve months ended December 31, 2011 were less than $10 million as reported in our audited financial statements, (i) the holders of our Preferred Stock received a warrant to purchase a number of shares of our common stock equal to fifty percent of the number of shares of common stock issuable upon conversion of the Preferred Stock at the Conversion Rate (the “Make Good Warrants”) and (ii) the Conversion Rate was adjusted to $1.00, subject to adjustments for stock splits and stock dividends (the issuance of the Make Good Warrants and the adjustment to the Conversion Rate is referred to as the “Make Good Adjustment”). The Make Good Warrants expire December 31, 2015 and have an initial exercise price of $1.00 per share and provide for cashless exercise at any time the underlying shares of common stock have not been registered for resale under the Securities Act of 1933 or are issuable without restriction pursuant to Rule 144 of the Securities Act.
15 |
During March and April 2011, we sold 759,773 shares of Preferred Stock at a price per share of $10, for gross proceeds of $7,597,730. We paid commissions, legal fees and other expenses of issuance of $828,340, which has been recorded as a discount and deducted from the face value of the Preferred Stock. This discount will be amortized over three years consistent with the initial redemption terms. During the three months ended March 31, 2012, we amortized approximately $68,000 of this discount. At issuance of the Preferred Stock, we attributed a beneficial conversion feature to the Preferred Stock based upon the difference between the Conversion Rate at the time of issuance and the closing price of our common stock on the date of issuance, which was recorded as a discount and deducted from the face value of the Preferred Stock. Pursuant to the Make Good Adjustment of the Conversion Rate to $1.00, at December 31, 2011 the beneficial conversion feature was recalculated as if the $1.00 Conversion Rate was in affect at issuance, and the amortization of the related discount was adjusted for the year ended December 31, 2011, resulting in an unamortized discount at December 31, 2011 of $1.6 million. This discount is amortized over three years consistent with the initial redemption terms, as a charge to additional paid-in capital, due to a deficit in retained earnings and during the three months ended March 31, 2012, we amortized approximately $174,000 to additional paid-in capital. At March 31, 2012, the unamortized Preferred Stock discount balance was $1.9 million.
During the three months ended March 31, 2012, we issued 62,500 shares of our common stock upon conversion of 6,250 shares of our Preferred Stock.
At March 31, 2012, we may be required to issue approximately 7.4 million shares of our common stock if the remaining holders of our Preferred Stock elect to convert. In addition, the holders of our Preferred Stock were issued warrants to purchase approximately 3.8 million shares of our common stock at an exercise price of $1.00 per share pursuant to the Make Good Adjustment. The fair value of the warrants issued represented the fair value of the derivative liability at December 31, 2011 when the warrants were effectively issued.
Since the Preferred Stock may ultimately be redeemed at the option of the holder, the carrying value of the shares, net of unamortized discount and accumulated dividends, has been classified as temporary equity at March 31, 2012.
For the three months ended March 31, 2012 we accrued dividends on the Preferred Stock in the amount of $171,751. This accrued dividend was paid with approximately 286,300 shares of common stock issued in lieu of cash subsequent to March 31, 2012.
The components of our 10% convertible redeemable preferred stock are summarized as follows:
March 31, | December 31, | |||||||
2012 | 2011 | |||||||
Redeemable preferred stock - face value | $ | 7,460,230 | $ | 7,522,730 | ||||
Accrued dividends | 171,751 | 176,620 | ||||||
Unamortized discount | (1,936,972 | ) | (2,179,094 | ) | ||||
Redeemable preferred stock, net of discount | $ | 5,695,009 | $ | 5,520,256 |
Placement Agent Warrants
We issued warrants to the placement agents for the sale of our 10% convertible preferred stock, to purchase 58,352 shares of 10% convertible preferred stock at $10 per share. Since the underlying 10% convertible preferred stock is redeemable by the holder after three years from the date of purchase, we recorded the fair value of the warrants at issuance, as a liability on our balance sheet and we re-value the warrant liability at each reporting date, with changes in fair value recognized in earnings each reporting period. We recognized a change in fair value of the warrant liability at March 31, 2012 of approximately $243,000, resulting in a warrant liability at March 31, 2012 of approximately $245,000.
Note 8 - Stockholder’s Equity
We are authorized to issue up to 100,000,000 shares of Common Stock, no par value, and up to 2,500,000 shares of Preferred Stock, no par value. There were 25,692,299 (including 250,000 shares of redeemable common stock) and 25,257,261 shares of common stock issued and outstanding at March 31, 2012 and December 31, 2011, respectively. During the year ended December 31, 2011, we designated 880,000 shares of preferred stock as 10% convertible preferred stock and had outstanding 746,023 and 752,273 shares of 10% convertible preferred stock at March 31, 2012 and December 31, 2011, respectively. We may issue additional shares of preferred stock, with dividend requirements, voting rights, redemption prices, liquidation preferences and premiums, conversion rights and other terms without a vote of the shareholders.
16 |
As of March 31, 2012, we had outstanding options, warrants and other convertible securities that, when exercised or converted, could result in the issuance of up to approximately 24.5 million shares of common stock.
Common Stock Issuances for the Three Months Ended March 31, 2012
During January 2012, we issued 125,000 shares of common stock with a fair value on the date of issuance of $90,000, to a consultant pursuant to the terms of an agreement to provide services.
We paid the December 31, 2011 accrued dividend on our 10% convertible preferred stock with 247,538 shares of our common stock, with a fair value on the effective date of the dividend of $176,620.
During March 2012, we issued 62,500 shares of common stock upon conversion of 6,250 shares of our 10% convertible preferred stock, with a value of $62,500.
Warrants - Common Stock
From time to time, we compensate consultants, advisors and investors with warrants to purchase shares of our common stock, in lieu of cash payments. Net share settlement is available to warrant holders. Such warrants are marked to market at each reporting period.
The following table sets forth our warrant activity during the periods presented.
Three Months Ended | Three Months Ended | |||||||||||||||
March 31, 2012 | March 31, 2011 | |||||||||||||||
Weighted- | Weighted- | |||||||||||||||
Number | Average | Number | Average | |||||||||||||
of Shares | Exercise | of Shares | Exercise | |||||||||||||
Issuable | Price | Issuable | Price | |||||||||||||
Beginning of period | 5,452,141 | $ | 1.18 | 5,329,783 | $ | 1.16 | ||||||||||
Granted during the period | 3,861,370 | 0.99 | 101,926 | 1.00 | ||||||||||||
Exercised during the period | - | - | (460,000 | ) | 0.60 | |||||||||||
End of period | 9,313,511 | 1.10 | 4,971,709 | 1.21 | ||||||||||||
Exercisable at end of period | 9,097,511 | $ | 1.11 | 4,683,709 | $ | 1.23 |
We estimated the fair value of each warrant at the grant date by using the Black-Scholes option pricing model with the following range of assumptions for the warrants granted during the three months ended March 31, 2012 - (i) no dividend yield, (ii) expected volatility of between 83% and 100%, (iii) risk-free interest rates of between 0.3% and 0.6%, and (iv) expected lives of between three years and four years.
Of the warrants to purchase shares of our common stock granted during the three months ended March 31, 2012, we issued warrants to purchase 3,761,365 shares of our common stock at a weighted average exercise price of $1.00 to the holders of our 10% convertible preferred stock pursuant to the Make Good Adjustment. Additionally we issued warrants to purchase 100,005 shares of our common stock at a weighted average exercise price of $0.60 to the holders of our 10% convertible debentures pursuant to their amended terms. These warrants had a fair value of $38,094 at the date of grant which was charged to interest expense during the period. The fair values at date of grant for the warrants were based on the Black-Scholes pricing model.
Warrants - 10% Convertible Preferred Stock
We issued warrants to the placement agents for the sale of our 10% convertible preferred stock, to purchase 58,352 shares of 10% convertible preferred stock at $10 per share. Since the underlying 10% convertible preferred stock is redeemable by the holder after three years from the date of purchase, we recorded the fair value of the warrants at issuance, as a liability on our balance sheet and we re-value the warrant liability at each reporting date, with changes in fair value recognized in earnings each reporting period. We recognized a change in fair value of the warrant liability at March 31, 2012 of approximately $243,000, resulting in a warrant liability at March 31, 2012 of approximately $245,000.
Note 9 - Share-based Compensation
We have two nonqualified stock option plans approved by shareholders with an aggregate of approximately 1.1 million shares remaining available for grant as of March 31, 2012. The exercise price of the options are established by the Board of Directors on the date of grant and are generally equal to the market price of the stock on the grant date. The Board of Directors may determine the vesting period for each new grant. Options issued are exercisable in whole or in part for a period as determined by the Board of Directors of up to ten years from the date of grant.
17 |
We estimated the fair value of each option award at the grant date by using the Black-Scholes option pricing model with the following range of assumptions for the awards during the three months ended March 31, 2012 - (i) no dividend yield, (ii) expected volatility of 125%, (iii) risk-free interest rates of between 0.8% and 0.9%, and (iv) expected lives of five years.
During the three months ended March 31, 2012, we awarded options to purchase 250,000 shares of our common stock at an exercise price of $0.72 per share, to an employee as a component of the optionee’s initial hiring compensation. The right to exercise certain of these options is based on the optionee’s achievement of specific objectives. As of March 31, 2012, the likelihood of, and the date on which the optionee might achieve the objectives were not apparent, therefore the fair value was not estimated. The remaining options had fair values at their date of grant which totaled $90,892 based on the Black-Scholes option pricing model. In addition, when it becomes more than likely that the optionee will achieve their stipulated objectives, the fair value will then be determined and the balance amortized to operating expenses. Additionally, during the three months ended March 31, 2012, we issued options to purchase 50,000 shares of our common stock at an exercise price of $0.74, to an advisory board member in recognition of services rendered and as an incentive for services to be rendered. These options had a fair value of $31,182 at the date of grant based on the Black-Scholes option pricing model. During the three months ended March 31, 2012, an employee met their stipulated objective of previously awarded options, which had a fair value on the date the objective was met of $32,403, which was charged to operating expenses during the period.
In addition to the charge to operating expenses during the three months ended March 31, 2012 for the fair value of options awarded and earned during the period, the fair value of certain options awarded in prior periods was amortized over their vesting periods during the three months ended March 31, 2012. During the three months ended March 31, 2012, $127,973 was recognized in operating expenses on the vesting of previously issued options. The total share-based compensation expense was approximately $227,000 for the three months ended March 31, 2012. The remaining unamortized fair value of $102,429 will be recognized over future vesting periods.
The following table summarizes our stock option activity for the periods presented:
Three Months Ended | Three Months Ended | |||||||||||||||
March 31, 2012 | March 31, 2011 | |||||||||||||||
Weighted- | Weighted- | |||||||||||||||
Number | Average | Number | Average | |||||||||||||
of Shares | Exercise | of Shares | Exercise | |||||||||||||
Issuable | Price | Issuable | Price | |||||||||||||
Beginning of period | 5,886,261 | $ | 1.11 | 3,488,761 | $ | 1.02 | ||||||||||
Granted during the period | 300,000 | 0.72 | 315,000 | 1.49 | ||||||||||||
Exercised during the period | - | - | - | - | ||||||||||||
Cancelled during the period | - | - | - | - | ||||||||||||
End of period | 6,186,261 | $ | 1.10 | 3,803,761 | $ | 1.06 | ||||||||||
Exercisable at end of period | 3,299,703 | $ | 1.04 | 1,401,685 | $ | 1.04 |
18 |
The following table summarizes options outstanding at March 31, 2012:
Number of Shares Issuable | Weighted- Average Exercise Price | Weighted- Average Remaining Term (Years) | Aggregate Intrinsic Value | |||||||||||||
Total shares issuable upon exercise | 6,186,261 | $ | 1.10 | 3.7 | $ | 485,230 | ||||||||||
Options exercisable | 3,299,703 | 1.04 | 3.2 | 142,307 | ||||||||||||
Options not vested | 2,886,558 | 1.17 | 4.1 | 342,923 |
Note 10 - Income Taxes
Due to our substantial operating losses and the valuation allowance applied against our deferred tax assets, we have not recorded any income tax expense or benefit. Income tax benefit attributable to loss before income taxes differed from the amounts computed by applying the United States of America federal tax rate of 40% to loss before income taxes as a result of the following:
March 31, | December 31, | |||||||
2012 | 2011 | |||||||
Current: | ||||||||
Federal | $ | - | $ | - | ||||
State | - | - | ||||||
- | - | |||||||
Increase in valuation allowance | (1,880,000 | ) | (260,000 | ) | ||||
Benefit of operating loss carry forward | 1,880,000 | 260,000 | ||||||
Provision for income taxes, net | $ | - | $ | - |
March 31, | December 31, | |||||||
2012 | 2011 | |||||||
Statutory federal income tax rate | 40.0 | % | 40.0 | % | ||||
Increase in valuation allowance | (40.0 | )% | (40.0 | )% | ||||
Effective tax rate | 0.0 | % | 0.0 | % |
Deferred income taxes result from temporary differences in the recognition of income and expenses for the financial reporting purposes and for tax purposes. At March 31, 2012, we had available net operating loss carry forwards of approximately $15.1 million that expire through 2032. Our ability to utilize our net operating loss carry forwards is uncertain and thus a valuation allowance has been provided against our net deferred tax asset. Due to the changes in ownership over the prior periods from debt conversions, equity financings and the merger transaction, we may have triggered a Section 382 limitation on the utilization of such net operating loss carry forwards. In addition, we have not remained current with our federal and state tax returns. The net deferred tax assets and liabilities are comprised of the following:
March 31, | December 31, | |||||||
2012 | 2011 | |||||||
Deferred tax assets: | ||||||||
Current | $ | - | $ | - | ||||
Non-current | 6,040,000 | 4,160,000 | ||||||
6,040,000 | 4,160,000 | |||||||
Less valuation allowance | (6,040,000 | ) | (4,160,000 | ) | ||||
Net deferred income tax asset | $ | - | $ | - |
19 |
Note 11 - Business Concentration
During the three months ended March 31, 2012, we sold our products to 9 customers, with sales of our ECOTRAX rail ties to one customer representing approximately 76% of our total revenue. For the three months ended March 31, 2011, we sold our products to six customers, with sales to one customer representing approximately 54% of our total revenue.
Although our purchases of raw materials and contract manufacturing services and products, included approximately twenty vendors, total dollar volume was concentrated in our two contract manufacturers during the three months ended March 31, 2012.
Note 12 - Commitments and Contingencies
Operating leases
We lease approximately 2,000 square feet of office space in New Providence, New Jersey pursuant to a three-year lease agreement for office space which provides for initial monthly lease payments of approximately $3,400 with customary annual increases. These premises serve as our corporate headquarters. The initial term of the lease expires on October 31, 2012 and the lease provides one renewal option for an additional three-year term. Facility rent expense for this facility totaled approximately $11,300 and $10,700 for the three months ended March 31, 2012 and 2011, respectively.
Future minimum rental payments for the remainder of the initial lease term totals approximately $26,300.
Rutgers License
In February 2007, we acquired an exclusive, royalty-bearing license in specific but broad global territories to make, have made, use, sell, offer for sale, modify, develop, import, and export products made using patent applications owned by Rutgers University (Rutgers”). We are using these patented technologies in the production of our composite rail ties and structural building products. The term of the License Agreement runs until the expiration of the last-to-expire issued patent within the Rutgers’ technologies licensed under the License Agreement, unless terminated earlier.
We are obligated to pay Rutgers royalties ranging from 1.5% to 3.0% on various product sales, subject to certain minimum payments each year and to reimburse Rutgers for certain patent defense costs in the case of patent infringement claims made against the Rutgers patents. We also pay annual membership dues to Rutgers Center for Advanced Materials via Immiscible Polymer Processing, or AIMPP, a department of Rutgers. The membership allows us to use AIMPP for basic research and development at no additional cost, with access to more comprehensive R&D services available to us for fees determined on a per-project basis.
Litigation
In April 2006, we commenced an action against Tonga Partners, L.P. (Tonga”), Cannell Capital, L.L.C. and J. Carlo Cannell in the United States District Court of New York, for disgorgement of short-swing profits pursuant to Section 16 of the Securities Exchange Act of 1934, as amended. On November 10, 2004, Tonga converted a convertible promissory note into 1,701,341 shares of Common Stock, and thereafter, between November 10 and November 15, 2004, sold such shares for short-swing profits. In September 2008, the District Court granted us summary judgment against Tonga for disgorgement of short-swing profits in the amount of $4,965,898. The defendants are appealing from the order granting the summary judgment.
From time to time, we are subject to various other routine litigation incidental to our business. We do not believe that any of these routine legal proceedings would have a material adverse effect on our financial condition or results of operations.
20 |
Note 13 - Related Party Transactions
Michael Dodd
Mr. Dodd, who has been a member of our board of directors since September 2010, is currently serving as the Chief Executive Officer of 3D Global Solutions Inc. (or 3D). 3D provides professional program management services to governments, corporations and global organizations. During the year ended December 31, 2011, 3D purchased approximately $102,200 of our composite rail ties on terms similar to our other customers and which remains uncollected at March 31, 2012.
Samuel G. Rose – Convertible Revolving Credit Agreement
Samuel G. Rose beneficially owns in excess of 5% of our outstanding stock. During the year ended December 31, 2011, we entered into a convertible revolving credit agreement (the Agreement”) with Mr. Rose. Under the terms of the Agreement, Mr. Rose has agreed to lend us up to $2,000,000 on a revolving basis (the Loan”). The Loan bears interest at 12% per annum on the outstanding principal amount. Mr. Rose may elect to have all or a portion of accrued interest paid in shares of our common stock. The common stock shall be valued at the lessor of (a) $0.80 per share or (b) $0.10 per share less than the variable weighted average price (VWAP”) for our common stock for the thirty days ending one trading prior to the date of issuance of such shares. The Loan will mature on September 30, 2012.
Mr. Rose may convert up to fifty percent of the trailing ninety day average of outstanding principal amount under the Loan into shares of our common stock. Such common stock shall be valued at the lessor of (a) $0.80 per share or (b) $0.10 per share less than the VWAP for our common stock for any thirty days ending one trading prior to the date of issuance of such shares.
In consideration for the Loan, we paid all legal and accounting costs associated with the documentation of the Loan and issued to Mr. Rose 250,000 shares of our restricted common stock. We have agreed to register the common stock issued to Mr. Rose within six months from date of closing provided, however, if such common stock is not registered we will redeem all of Mr. Rose’s unregistered stock in cash at a price equal to the greater of (a) the average VWAP for the thirty days ending one trading day prior to the date of issuance or (b) $0.90 per share. Mr. Rose agreed to waive any notice requirements under the Agreement in connection with our proposed sale of certain securities pursuant to a registration statement on Form S-1, which we initially filed on December 22, 2011 and may amend from time to time thereafter.
We gave Mr. Rose a security interest in our inventory and accounts receivable pursuant to terms of a security agreement.
During the year ended December 31, 2011, we borrowed $466,000 under the Agreement, which is still outstanding at March 31, 2012. Subsequent to March 31, 2012,we repaid the outstanding principal and accrued interest and the Agreement was cancelled.
Note 14 - Subsequent Event
Convertible Revolving Credit Agreement
Subsequent to March 31, 2012, we repaid the outstanding principal and accrued interest outstanding on our convertible revolving credit agreement which was then cancelled.
Demand Promissory Notes
Subsequent to March 31, 21012 we entered into a Memorandum of Understanding (the “MOU”) with Melvin Lenkin (“Lenkin”), Samuel Rose (“Rose”) and Allen Kronstadt (“Kronstadt” and collectively with Lenkin and Rose, the “Investors”). Pursuant to the MOU, we agreed to issue to the Investors or their assigns demand promissory notes (collectively, the “Demand Notes”) in the aggregate principal amount of $5,000,000. Interest accrues on the unpaid principal balance of the Demand Notes at a rate of 8.00% per annum. The principal balance of the Demand Notes, together with accrued and unpaid interest, is due and payable at any time after June 30, 2012 on demand. The issuance of such Demand Notes was made in reliance upon the exemption from registration afforded by Section 4(2) of the Securities Act of 1933, as amended.
21 |
Pursuant to the terms of the MOU, we agree to use commercially reasonable efforts to negotiate and execute definitive agreements pursuant to which the Investors shall severally purchase an aggregate of $10,000,000 of convertible debt from us, $5,000,000 of which will be paid for by converting the outstanding principal balance of the Demand Notes, and $5,000,000 of which will be paid for in cash on December 1, 2012.
22 |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The discussion of our financial condition and results of operations set forth below should be read in conjunction with the consolidated financial statements and related notes thereto included elsewhere in this Form 10-Q. This Form 10-Q contains forward-looking statements that involve risk and uncertainties. The statements contained in this Form 10-Q that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. When used in this Form 10-Q, or in the documents incorporated by reference into this Form 10-Q, the words “anticipate,” “believe,” “estimate,” “intend”, “expect”, “may”, “will” and similar expressions are intended to identify such forward-looking statements. Such forward-looking statements include, without limitation, statements relating to competition, management of growth, our strategy, future sales, future expenses and future liquidity and capital resources. All forward-looking statements in this Form 10-Q are based upon information available to us on the date of this Form 10-Q, and we assume no obligation to update any such forward-looking statements. Our actual results, performance and achievements could differ materially from those discussed in this Form 10-Q. Factors that could cause or contribute to such differences (“Cautionary Statements”) include, but are not limited to, those discussed in Item 1A. “Risk Factors” and elsewhere in our Annual Report on Form 10-K. All subsequent written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the Cautionary Statements.
Basis of Presentation
The financial information presented in this Form 10-Q is not audited and is not necessarily indicative of our future consolidated financial position, results of operations or cash flows. Our fiscal year-end is December 31, and our fiscal quarters end on March 31, June 30 and September 30. Unless otherwise stated, all dates refer to our fiscal year and fiscal periods.
Overview
Our predecessor company was formed in 1981 under the name Analytic Surveys, Inc. On March 20, 2008, Analytic Surveys, Inc. consummated an Agreement and Plan of Merger (or the Merger) with Axion International, Inc. In the Merger, the stockholders of Axion International, Inc. succeeded to approximately 90.7% of Analytic Survey, Inc.’s issued and outstanding common stock and Analytics Survey changed its name to Axion International Holdings, Inc. The Merger has been accounted for as a reverse merger in the form of a recapitalization with Axion as the successor.
Axion manufactures, markets and sells composite rail ties and structural building products, such as pilings, I-beams, T-beams and boards which, based upon patented technology and know-how, are fully derived from common recycled plastics and high-density polymers, such as polyethylene, polystyrene and polypropylene. We market our products under two lines, “EcoTrax,” our line of rail ties, and “StruXure,” our line of structural building products.
Sources of Revenues
We derive our revenues through the sale of our EcoTrax rail ties and StruXure building products. Our strategic focus has been to advance rapidly the sale of our EcoTrax rail ties and to create a broad-based market for our StruXure building products. We have been undertaking strategic initiatives, including the ongoing development and deployment of engineering guidance materials, such as supporting documentation, research and other publications of the structural properties and performance of our products, with the goal to educate the engineers, developers and others who might use our products in projects for their clients, as well as our potential customers.
In late 2010, we commenced the sales and marketing of our products. Having completed a number of commercially engineered solution projects over the past several years, we began concentrating our activities from proof-of-concept to a strategically focused, sales-oriented growth company. Over the past several years, our activities centered upon advancing the development of our technology and products. As proof-of-concept, we completed the deployment of our products across multiple customers, applications and industries. Beginning late in 2010 we began introducing our EcoTrax rail products to mass markets globally and, during the year ended December 31, 2011, we developed and began implementing a sales strategy for our StruXure building products to other public- and private-sector buyers. Our strategic focus is on the continued growth of sales, within both the rail tie and the structural building products sectors, the expansion of our technology within and across markets, and the expansion of our infrastructure in order to manufacture our products and support our growing sales order pipeline.
23 |
Cost of Sales and Operating Expenses
Costs of Sales. Our costs of sales are primarily comprised of the cost of raw materials and the costs and expenses associated with our contract manufacturing arrangements. The price of the raw materials depends principally on the stage and source of the supply. We purchase the raw materials in various stages, from bulk plastic containers, which require further processing before use, to ready-for-production material. Typically, the more processed raw material is more expensive, on a per-pound basis, than less processed material. Likewise, raw materials purchased through third-party brokers or other intermediaries are more expensive than materials purchased directly from the source or collection point.
Our strategy to reduce our raw material costs include, broadening our raw materials sources and purchasing other low-cost, unprocessed materials, such as other scrap materials containing our specific raw materials from unique sources and recycled materials from municipal and other recycling collection sources. Previously, due to the limited amount of time and personnel we could devote to raw materials sourcing, we acquired our raw materials primarily from intermediaries, and purchased production-stage material, which resulted in the acquisition of raw materials at less-than favorable prices. Currently, we primarily acquire raw materials in bulk form, resulting in more favorable prices. As the cost of our raw materials is the single largest determinant of our costs of sales, we continue to seek out (i) agreements with sources of cheaper raw materials, while ensuring those materials meet or exceed our quality standards as well as (ii) expanding our research and development effort of different raw materials which may provide a cost and/or performance advantage over existing materials.
We are continuing to take steps to reduce our production costs and expenses, while increasing capacity. During the second half of the year ended December 31, 2011, we significantly increased production capacity, both through a focused joint effort with our existing contract manufacturer, as well as adding a second contract manufacturer. Our existing contract manufacturing agreements allow for the production of our products utilizing our manifolds, molds and controllers. Under one arrangement, we source, purchase and supply the contract manufacturer with the raw materials and pay a per pound manufacturing cost to our contract manufacturer to produce the finished products. Under the other arrangement, the contract manufacturer is responsible to sourcing and purchasing the raw materials and producing the finished product, which we purchase from them at a predetermined cost. Pursuant to that agreement, the predetermined cost is based on a reference price of each raw material, and we are obligated to reimburse the contract manufacturer for any costs it incurs in excess of the reference price and we share in any savings resulting from raw material purchases below the reference price. In addition to eliminating our cost and expense of sourcing the raw materials, we have improved our cash flow by eliminating the need to expend funds early in the manufacturing-to-sales cycle to purchase the raw materials, and instead purchase the finished product closer to the sale to our customer.
Additionally, during the three months ended March 31, 2012, we continued our efforts in driving unnecessary costs and expenses out of our manufacturing processes through the coordinated efforts of both our contract manufacturers and us. Each step of the manufacturing process, from raw material handling and storage through the quality control review and inventory handling steps, we’ve jointly examined best practices and other methods to improve and streamline the processes to eliminate unnecessary costs and expenses. We’ve made some improvements and continue to search out ways to continue to reduce the costs of manufacturing our products.
Even with the fluctuations in the prices in the raw materials market, the steps we have taken during the three months ended March 31, 2012-from the sourcing of our raw materials to the relationships with our contract manufacturers-should continue to benefit us in reducing and controlling our costs of sales.
Product Development and Quality Management. Product development and quality management expenses are incurred as we perform ongoing evaluations of materials and processes for existing products, as well as the development of new products and processes. Such expenses typically include costs associated with the design and the required testing procedures associated with our two product lines. In addition to our investment in both our product development efforts and insuring the products we produce meet the high quality specifications we’ve set, we continue to work with the scientific team at Rutgers University to enhance our product formulations, develop innovative products and expand the reach of our existing products.
24 |
Marketing and Sales. Expenses related to marketing and sales consist primarily of compensation for our sales and marketing personnel, sales commissions and incentives, advertising, trade shows and related travel. We have increased our marketing and sales effort and anticipate incurring significant marketing and sales expenses in the future. The strategy we employ in reaching out to our target markets-whether through collaborative approaches, such as joint ventures, by building our own sales and marketing infrastructure, or by sub-licensing our technology to others-will have a significant effect on our marketing and sales expenses. We expect that in the future, marketing and sales expenses will increase in absolute dollars.
General and Administrative. General and administrative expenses consist of compensation and related expenses for executive, finance, accounting, administrative, legal, shareholder services, depreciation of general office equipment and other corporate expenses. We anticipate that we will continue to use share-based compensation when compensating consultants and others, in certain situations. In addition, we anticipate as we continue to grow our business, our general and administrative expenses will increase. As a result, we expect that in subsequent periods, general and administrative expenses will increase in absolute dollars as revenue increases.
Interest Expense and Amortization of Debt and Preferred Stock Discounts. Interest expense primarily consists of the contractual interest rate we pay on our convertible debt instruments. Amortization of debt and preferred stock discounts consists of the periodic amortization of the debt discounts associated with our convertible debt, the amortization of the fair value of the bonus warrants issued to the holders of the convertible debt, and the amortization of the 10% convertible preferred stock discount.
Gain or Loss from Change in Fair Value of Derivative Liability. During the year ended December 31, 2011, we entered into a revolving credit agreement which gave the holder the right to convert a portion of the outstanding debt into shares of our common stock. We recognized the fair value of this beneficial conversion feature at the date we executed the agreement and at the end of each reporting period, recognizing the change in earnings during the current period. Pursuant to the terms of our preferred stock, we were required to issue warrants to the holders of the preferred stock. At initial issuance of the preferred stock, we recorded the fair value as a derivative liability and recognized the change in fair value in current earnings. During the three months ended March 31, 2012, we issued the warrants and reclassified the fair value of the warrants as represented by the derivative liability upon issuance of the warrants, to Common Stock.
Critical Accounting Policies
Management’s Discussion and Analysis of Financial Condition and Results of Operations are based upon our financial statements, which have been prepared in accordance with generally accepted accounting principles (or GAAP) in the U.S. The preparation of financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. Our critical accounting policies are those that affect our financial statements materially and involve difficult, subjective or complex judgments by management.
An accounting policy is deemed to be critical if it requires an accounting estimate to be made based on assumptions about matters that are highly uncertain at the time the estimate is made, and if different estimates that reasonably could have been used or changes in the accounting estimate that are reasonably likely to occur could materially change the financial statements.
Use of Estimates. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Revenue and Cost Recognition. We recognize revenue when a fixed commitment to purchase our products is received, title or ownership has passed to the customer, the amount due from the customer is fixed or determinable, collectability is reasonably assured, and we do not have any specific performance obligations remaining, such that the earnings process is complete. In most cases, we receive a purchase order from our customer specifying the products requested and delivery instructions. We recognize revenue upon our delivery of the products as specified in the purchase order.
25 |
In other cases where we have a contract which provides for a large number of products and few actual deliveries, the revenues are recorded each month as the products are produced and the risk of ownership passes to the customer upon pre-delivery acceptance. Prior to deliveries, our customer’s products are segregated from our inventory and not available for fulfilling other orders.
Stock-based Compensation. We recognize stock-based compensation for transactions in which we exchange our equity instruments for services of directors, employees, consultants and others based on the fair value of the equity instruments issued at the date of grant or other measurement date. The fair value of common stock awards is based on the observed market value of our stock. We calculate the fair value of options and warrants using the Black-Scholes option pricing model. The Black-Scholes model requires the input of subjective assumptions including volatility, expected term, risk-free interest rate and dividend yield. We use a measure of volatility based on the historical volatility of our common stock over a similar period to the expected life of the award. The expected term of an award is based on the vesting period. We base the risk-free rate on the rate of U.S. Treasury obligations with maturities similar to the expected term used in the model. Historically, we have not, and do not anticipate paying in the foreseeable future, dividends on our common stock, and accordingly use an expected dividend yield of zero.
Derivative Instruments.For derivative instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in fair value recognized in earnings each reporting period. We use the Black-Scholes model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as a liability or as equity, is re-assessed at the end of each reporting period, in accordance with FASB ASC Topic 815,“Derivatives and Hedging”. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date.
Recent Accounting Pronouncements
For information regarding recent accounting pronouncements and their effect on us, see “Recent Accounting Pronouncements” in Note 1 of the unaudited Notes to Condensed Consolidated Financial Statements contained herein.
Results of Operations– Three Months Ended March 31, 2012 and 2011
The following discussion should be read in conjunction with the information set forth in the unaudited condensed consolidated financial statements and the related notes thereto appearing elsewhere in this Form 10-Q
Revenue. For the three months ended March 31, 2012 and 2011, we recognized revenue of $2.3 million and $0.2 million, respectively which included revenue from the sales of our EcoTrax, our composite rail ties of $2.2 million and $0.2 million, respectively during those periods. The remainder of our revenue during the three months ended March 31, 2012, was from our sales of our StruXure composite structural building products. Approximately 76% of our sales during the three months ended March 31, 2012 were to one customer pursuant to a three-year supply agreement of our EcoTrax rail ties. This contract contains challenging pricing terms, but it has provided us with the base to develop and expand our manufacturing capacity and processes during the past twelve months. Our focus will continue to be on diversifying our customer base and the pricing of our products, as well as the continuing development of opportunities we foresee with our StruXures composite structural building products.
Costs of Sales. Cost of sales amounted to $2.3 million and $0.3 million for the three months ended March 31, 2012 and 2011, respectively, resulting in gross margins of approximately $11,000 and costs of sales were in excess of our sales by $85,000, respectively. The gross margin for the three months ended March 31, 2012, is a result of our early stage of our manufacturing and commercial activities and included, among other factors, inefficient manufacturing processes and methods and higher than anticipated costs and expenses of the raw materials used in production. We continue to work to improve our manufacturing processes and procedures to remove unnecessary and inefficient costs and expenses. During the three months ended March 31, 2012, we continued to experience the challenge of sourcing raw materials at prices which would benefit our gross margins. We met with some success during the three months ended March 31, 2012, in finding new sources of raw materials, either containing a higher percentage of our individual raw material components on a per pound basis or at a significant price advantage. We anticipate that a combination of enhanced manufacturing methods, processes and procedures in addition to reduced costs of raw materials will have a positive impact on our gross margins in subsequent periods.
26 |
During the three months ended March 31, 2011, our cost of sales included approximately $38,000 in freight charges which we were not able to recapture as we launched our sales-oriented growth strategy.
Because we are in the early stages of commercial activities, cost of sales may not be indicative of cost of sales in the future, which may vary significantly and are highly dependent on the price of raw materials, concurrent production activities, use of subcontractors and timing and mix of the sales and services.
Product Development and Quality Management. Costs and expenses associated with our product development and quality management efforts were $235,000 and $73,000 for the three months ended March 31, 2012 and 2011, respectively. This increase reflects the expansion of our quality management efforts within our third-party manufacturing processes, enhance our product formulations, develop new innovative products, and expand the reach of our existing products.
Marketing and Sales. Marketing and sales expenses increased to $139,000 for the three months ended March 31, 2012 compared to $59,000 for the corresponding period in 2011. The increase reflects an increased effort in establishing our EcoTrax and StruXures brands through effective and efficient branding strategies and the marketing efforts in support thereof.
General and Administrative. General and administrative costs totaled approximately $0.8 million and $1.5 million for the three months ended March 31, 2012 and 2011, respectively. During the three months ended March 31, 2012 and 2011, we recorded approximately $336,000 and $952,000, respectively in charges related to the fair value of the shares of our common stock and options and warrants providing the right to purchase shares of our common stock at a predetermined price in the future, issued prior to and during the period. During the three months ended March 31, 2012, we issued shares of common stock in lieu of cash payments, with a fair value on the date of issuance of $90,000, in connection with services rendered by a consultant. In addition, during the period we issued options and warrants as compensation to an employee, as well as to a consultant resulting in a charge to general and administrative expenses for the three months ended March 31, 2012 of $99,000, representing the amortization of the fair value of the options awarded. We recognized the change in fair value of our 10% convertible preferred stock warrants liability at March 31, 2012 of approximately $243,000 during the three months ended March 31, 2012.
Interest Expense. Interest expense recognized during the three months ended March 31, 2012 and 2011, was approximately $38,000 and $30,000, respectively, and represented the contractual interest rates payable on our debt obligations.
Amortization of Debt and Preferred Stock Discounts. During the three months ended March 31, 2012 and 2011, we recognized approximately $311,000 and $204,000, respectively for the amortization of convertible debt discounts, the amortization of the fair value of warrants issued as additional interest pursuant to our amended convertible debentures, and the amortization of our convertible preferred stock discount. The fair value of warrants issued as additional interest on our convertible debt for the three months ended March 31, 2012, was approximately $38,000. There were no warrants issued for additional interest on the convertible debt during the corresponding period in 2011. At the time of issuance, we recorded discounts on our convertible securities primarily due to the imbedded conversion features, the fair value of any related shares of common stock or warrants issued in conjunction with the securities and any costs incurred in issuing the security. These discounts are amortized over the term of the underlying convertible security, to stockholders’ deficit in the case of the imbedded beneficial conversion feature and warrants issued pursuant to the convertible preferred stock and to expense in the case of the shares of common stock or warrants and costs of issuances. Any unamortized discount remaining when the security is repaid or converted is written off to expense in that period.
At March 31, 2012, the unamortized discounts of our convertible securities were approximately $2.2 million, which consisted of an approximately $306,000 discount associated with our convertible debt and approximately $1.9 million of discount associated with our 10% convertible preferred stock. The unamortized discount associated with the convertible debt will be fully amortized on June 30, 2012. The unamortized discount associated with the convertible preferred stock is being amortized over three years (the period of time after which the preferred stock may be redeemed), through April 2014.
27 |
Gain or Loss from Change in Fair Value of Derivative Liability. During the year ended December 31, 2011, we entered into a revolving credit agreement and pursuant to the agreement we recognized the fair value of the embedded beneficial conversion feature as a derivative liability. To recognize the change in fair value of the derivative liability at March 31, 2012 we recorded a loss of $13,800. Pursuant to the terms of our preferred stock, we were required to issue warrants to the holders when we did not achieve $10 million in revenue for the year ended December 31, 2011.At the date of issuance of the preferred stock in March and April 2011, we determined the fair value of the warrant derivative liability to be insignificant and did not record a charge to Common Stock and a credit to the derivative liability.Later in 2011, since it became probable that the revenue milestone would not be met, we recorded the fair value of these warrants of $2.4 million as a derivative liability. The fair value of these warrants at December 31, 2011 was $1.9 million. During the three months ended March 31, 2012, we issued the warrants and reclassified the fair value of the warrants of $1.9 million, as represented by the derivative liability immediately upon issuance of the warrants, to Common Stock.During the three months ended March 31, 2011, we did not have a derivative liability and therefore we did not recognize any change in fair value.
Income Taxes. We have unused net operating loss carry forwards, which included losses incurred from inception through March 31, 2012. Due to the uncertainty that sufficient future taxable income will be recognized to realize associated deferred tax assets, no income tax benefit from inception through March 31, 2012 has been recorded.
Liquidity, Capital Resources and Plan of Operations
At March 31, 2012 we had approximately $3.5 million in current assets and $3.3 million in current liabilities resulting in working capital of $190,000. This compares to working capital of approximately $164,000 million at December 31, 2011.
We used approximately $176,000 in our operating activities during the three months ended March 31, 2012. During the three months ended March 31, 2012, we recorded approximately $453,000 in non-cash transactions, consisting of depreciation and amortization, accretion of debt discounts, changes in fair value of liabilities and share-based compensation expense. The changes in our current assets and liabilities consisted primarily of an increase in our accounts payable of $838,000 from December 31, 2011 to March 31, 2012.
To increase production capacity, we purchased property and equipment of approximately $527,000 during the three months ended March 31, 2012. We anticipate purchasing additional property and equipment as we continue to expand our manufacturing capacity. We spend between approximately $0.7 million and $1.0 million to have a typical production line made, delivered and installed.
At maturity on January 31, 2012, we repaid the principal of $172,500 and accrued interest on our 8.75% convertible debenture. At March 31, 2012, we had $600,000 of our 10% convertible debentures outstanding which are due on June 30, 2012. In addition, at March 31, 2012 we had $466,000 of our convertible revolving credit agreement outstanding which was repaid in full, subsequent to March 31, 2012.
Pursuant to the terms of the 10% convertible preferred stock, to date we have elected to pay our quarterly dividends in shares of our common stock, rather than in cash. Whether or not we make the same election for future quarters will have an impact on our cash balances.
Subsequent to March 31, 21012 we entered into a Memorandum of Understanding (the “MOU”) with investors (the “Investors”). Pursuant to the MOU, we issued to the Investors demand promissory notes in the aggregate principal amount of $5,000,000. Interest accrues on the unpaid principal balance of the demand promissory notes at a rate of 8.00% per annum. The principal balance of the demand promissory notes, together with accrued and unpaid interest, is due and payable at any time after June 30, 2012 on demand. Pursuant to the terms of the MOU, we agreed to use commercially reasonable efforts to negotiate and execute definitive agreements pursuant to which the Investors shall severally purchase an aggregate of $10,000,000 of convertible debt from us, $5,000,000 of which will be paid for by converting the outstanding principal balance of the demand promissory notes, and $5,000,000 of which will be paid for in cash on December 1, 2012.
Our ability to redeem our convertible preferred stock or common stock when, and if, redeemed by the holders, pay principal and interest on the demand promissory notes issued subsequent to March 31, 2012, pay principal and interest on our remaining outstanding debt and to fund our planned operations, including certain minimum royalties pursuant to our license agreement with Rutgers University, depends on our future operating performance and our ability to raise capital. The timing and amount of our financing needs will be highly dependent on our ability to manufacture our products at a cost which provides for an appropriate return, the success of our sales and marketing programs, our ability to obtain purchase commitments, the size of such purchase commitments and any associated working capital requirements.
28 |
Our current operating plans are to enhance and expand our manufacturing capacity to meet our customer commitments, continue to expand our marketing and sales capabilities to increase our pipeline of sales orders, and continue to develop innovative solutions for our customers. Although we have raised additional funds through the issuance of our 10% convertible preferred stock and are currently exploring other financing sources, there can be no assurance that we will achieve our financing needs at all or upon terms acceptable to us. Further, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock.
Disclosure About Off-Balance Sheet Arrangements
We do not have any transactions, agreements or other contractual arrangements that constitute off-balance sheet arrangements.
Item 3. Quantitative and Qualitative Disclosures About Market Risks.
Not applicable.
Item 4. Controls and Procedures
(a) Evaluation of disclosure controls and procedures.
With the participation of our chief executive officer and chief financial officer, we evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Exchange Act. In designing and evaluating the disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that we are required to apply our judgment in evaluating the benefits of possible controls and procedures relative to their costs.
Based on our evaluation, our chief executive officer and chief financial officer concluded that, as a result of the material weaknesses described below, as of March 31, 2012, our disclosure controls and procedures are not designed at a reasonable assurance level and are ineffective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure. The material weaknesses, which relate to internal control over financial reporting, that were identified are:
(i) | We did not maintain sufficient personnel with an appropriate level of technical accounting knowledge, experience, and training in the application of GAAP commensurate with our complexity and our financial accounting and reporting requirements. We have limited experience in the areas of financial reporting regarding complex financial instruments. As a result, there is a reasonable possibility that material misstatements of the consolidated financial statements, including disclosures, will not be prevented or detected on a timely basis. For example, on May 10, 2012, we became aware that we had failed to recognize a warrant derivative liability with respect to our 10% Convertible Preferred Stock and the subsequent measurement of fair value of the warrant derivative liability, as required by Accounting Standards Codification 815-40. As a result, we determined that our consolidated financial statements for the year ended December 31, 2011 filed in the Annual Report on Form 10-K and our consolidated financial statements as of and for the three month period ended September 30, 2011 filed in the quarterly report on Form 10-Q (collectively, the “Reports”) should not be relied upon and needed to be restated.; and |
29 |
(ii) | Due to our small size, we do not have a proper segregation of duties in certain areas of our financial reporting and other accounting processes and procedures. This control deficiency, results in a reasonable possibility that material misstatements of the consolidated financial statements will not be prevented or detected on a timely basis. |
We are committed to improving our financial organization. As part of this commitment, in May 2012, we adopted additional processes and procedures over financial reporting as a result of the failure in recognizing the warrant derivative liability issue that resulted in the amendment to our Reports. If the issuance of any securities is contemplated, we will consult with legal counsel and appropriate accounting resources to evaluate the financial statement impact that the issuance of such financial instruments may have prior to issuance. Additional measures may be implemented as we evaluate the effectiveness of these efforts. We cannot assure you that these remediation efforts will be successful or that our internal control over financial reporting will be effective in accomplishing the control objectives.
In addition, we will continue to evaluate the need and costs to increase our personnel resources and technical accounting expertise within the accounting function to resolve non-routine or complex accounting matters. As our operations are relatively small and we continue to have net cash losses each quarter, we do not anticipate being able to hire additional internal personnel until such time as our operations are profitable on a cash basis or until our operations are large enough to justify the hiring of additional accounting personnel. As necessary, we may engage consultants in the future in order to ensure proper accounting for our consolidated financial statements.
We believe that engaging additional knowledgeable personnel with specific technical accounting expertise will remedy the following material weakness: insufficient personnel with an appropriate level of technical accounting knowledge, experience, and training in the application of GAAP commensurate with our complexity and our financial accounting and reporting requirements.
We believe that when the circumstances allow for the hiring of additional personnel who have the technical expertise and knowledge with the non-routine or technical issues we have encountered in the past, will result in both proper recording of these transactions and a much more knowledgeable finance department as a whole. Due to the fact that we have a limited internal accounting staff, additional personnel will also allow for the proper segregation of duties and provide more checks and balances within the department. Additional personnel will also provide the cross training needed to support us if personnel turn-over issues within the department occur. We believe this will greatly decrease any control and procedure issues we may encounter in the future.
(b) Changes in internal control over financial reporting.
We regularly review our system of internal control over financial reporting and make changes to our processes and systems to improve controls and increase efficiency, while ensuring that we maintain an effective internal control environment. Changes may include such activities as implementing new, more efficient systems, consolidating activities, and migrating processes. There were no changes in our internal control over financial reporting that occurred during the quarter ended March 31, 2012 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
30 |
PART II. OTHER INFORMATION
Item 1. Legal Proceedings.
None.
Item 2. Unregistered Sales of Securities and Use of Proceeds.
During January 2012, we issued 125,000 shares of common stock with a fair value on the date of issuance of $90,000, to a consultant pursuant to the terms of an agreement to provide services.
In January 2012, we issued 247,538 shares of common stock as payment of, in lieu of cash, the dividends on our 10% convertible preferred stock accrued at December 31, 2011, with a fair value at date of issue of $176,620.
During March 2012, we issued 62,500 shares of common stock upon conversion of 6,250 shares of our 10% convertible preferred stock, with a value of $62,500.
During the three months ended March 31, 2012, we issued warrants to purchase 100,005 shares of our common stock at a weighted average exercise price of $0.60 per share, to debenture holders pursuant to the amended terms of our 10% convertible debentures due in June 2012. The warrants had a fair value of approximately $38,000 at the date of grant based on the Black-Scholes pricing model, which was recognized in operating expense during the period.
Pursuant to the terms of our 10% convertible preferred stock, during March 2012 we issued warrants to purchase 3,761,365 shares of our common stock at a weighted average exercise price of $1.00 per share. The fair value of the warrants was $1.9 million, representing the fair value of the derivative liability of the warrants immediately before issuance.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
(Not Applicable)
Item 5. Other Information.
None.
31 |
Item 6. Exhibits.
Exhibits: | |
31.1 | Section 302 Certification of Chief Executive Officer |
31.2 | Section 302 Certification of Principal Financial Officer |
32.1 | Section 906 Certification of Chief Executive Officer and Chief Financial Officer |
32 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Axion International Holdings, Inc. | ||
Date: May 21, 2012 | /s/ Steven Silverman | |
Steven Silverman | ||
Chief Executive Officer | ||
Date: May 21, 2012 | /s/ Donald Fallon | |
Donald Fallon | ||
Chief Financial Officer |
33 |